Quantcast

Latest Cancer treatments Stories

2014-04-07 16:25:44

Largest-ever gift to the Hutch promises to save lives by broadening the application of immunotherapy to lung, ovarian, pancreatic and colon cancers SEATTLE, April 7, 2014 /PRNewswire/ -- Fred Hutchinson Cancer Research Center scientists striving for new cancer cures -- and the patients who stand to benefit from them -- got an enormous boost today when the Bezos family committed $20 million to support the development of novel cancer immunotherapies. It is the largest single...

2014-04-07 08:29:57

PRINCETON, N.J., April 7, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Dental and Craniofacial Research (NIDCR) has awarded Soligenix a Small Business Innovation Research (SBIR) grant...

2014-04-04 23:36:36

Active research in breast cancer is producing novel targeted drugs at a rapid pace. Thousand Oaks, California (PRWEB) April 03, 2014 As the Cancer society continues research for breast cancer, several options have emerged. Of these options three drugs have been approved by the FDA for usage as treatment and no one is more excited than Dr. Mai Brooks. Perjeta (pertuzumab) In September 2013, the FDA approved Perjeta for use in combination with Herceptin (trastuzumab) and docetaxel for the...

2014-04-04 23:27:07

Immunotherapy is one of the most exciting new approaches to treating cancer. Dr. Carl June will discuss his findings May 14 as featured speaker at UC San Diego. (PRWEB) April 04, 2014 A world leader in immunotherapy, Carl June, will discuss the emergence of a new form of targeted immunotherapy to treat cancer, Wednesday, May 14, 5:30 pm to 7 pm., at UC San Diego. June, professor of immunotherapy at the University of Pennsylvania, will discuss his pioneering work and also the barriers and...

2014-03-31 10:00:45

Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging. Researchers measured the level of p16, a protein that causes cellular aging, in the blood of 33 women over the age of 50 who had undergone chemotherapy for curable breast...

2014-03-31 09:54:57

UT Southwestern Medical Center researchers are developing a new predictive tool that could help patients with breast cancer and certain lung cancers decide whether follow-up treatments are likely to help. Dr. Jerry Shay, Vice Chairman and Professor of Cell Biology at UT Southwestern, led a three-year study on the effects of irradiation in a lung cancer-susceptible mouse model. When his team looked at gene expression changes in the mice, then applied them to humans with early stage cancer,...

2014-03-31 08:29:19

SANTA MONICA, Calif., March 31, 2014 /PRNewswire/ -- Kite Pharma, Inc. (Kite), a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT(TM)) products for cancer, today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation for the Company's lead investigational therapy, an autologous engineered T cell product that targets CD19 expression on B cell malignancies, for...

2014-03-31 08:28:39

Patients in Ontario and Atlantic Canada face significant challenges accessing oral medications due to their age, cancer type and where they live TORONTO, March 31, 2014 /CNW/ - The CanCertainty Coalition - an unprecedented unification of more than 30 Canadian patient groups, physicians, and health charities today released a powerful video highlighting the significant challenges cancer patients in Ontario and Atlantic Canada face in accessing oral medications. The video's message...

2014-03-29 23:01:54

A new study finds that a drug that kills bladder cancer cells with light works even better when another compound is added. Raleigh, NC (PRWEB) March 29, 2014 The Chinese developers of a light-based treatment for bladder cancer say the treatment can be improved with the addition of a second drug. Click here to read the findings, which have just been posted on the Cancer Monthly website. Doctors in the Department of Urology at Fudan University in Shanghai have concluded that the...

2014-03-27 08:34:30

BETHESDA, Md., March 27, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for cancer, announced today that Linda Powers, CEO, will present at the 4(th) Annual "Cancer Immunotherapy: A Long-Awaited Reality" conference being held at the New York Academy of Medicine in New York City on Thursday, March 27 at 2:45 pm ET. During her presentation, Ms. Powers will provide an...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related